Phythera Therapeutics, Inc.
Phythera Therapeutics is a biotechnology company focused on developing novel oncology treatments by enhancing plant-derived compounds. They aim to convert natural medicines into prescription drugs (Rx) by improving their bioavailability, stability, safety, and efficacy. Their mission is to create breakthrough cancer medicines with minimal harmful side effects, unlike traditional chemotherapy and radiation. Phythera leverages scientific advancements like liposomal drug delivery, small molecule conjugation, and AI-driven drug design. They utilize the FDA's botanical drug development pathway, treating plant extracts as single active ingredients, and consider the history of human use in their trials. Their strategy involves enhancing botanicals with long histories of safe human use and indications of efficacy, with their first candidate drug being MetPhyte™ Plus.
Phythera Therapeutics, Inc.
Phythera Therapeutics is a biotechnology company focused on developing novel oncology treatments by enhancing plant-derived compounds. They aim to convert natural medicines into prescription drugs (Rx) by improving their bioavailability, stability, safety, and efficacy. Their mission is to create breakthrough cancer medicines with minimal harmful side effects, unlike traditional chemotherapy and radiation. Phythera leverages scientific advancements like liposomal drug delivery, small molecule conjugation, and AI-driven drug design. They utilize the FDA's botanical drug development pathway, treating plant extracts as single active ingredients, and consider the history of human use in their trials. Their strategy involves enhancing botanicals with long histories of safe human use and indications of efficacy, with their first candidate drug being MetPhyte™ Plus.